| Clinical data | |
|---|---|
| Other names | PH; 4-Phenoxy-3,5-dimethoxyphenethylamine; 3,5-Dimethoxy-4-phenoxyphenethylamine |
| Routes of administration | Unknown |
| ATC code |
|
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C16H19NO3 |
| Molar mass | 273.332 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Phescaline (PH), also known as 4-phenoxy-3,5-dimethoxyphenethylamine, is a chemical compound of the phenethylamine and scaline families related to the psychedelic drug mescaline. It is the derivative of mescaline in which the methoxy group at the 4 position has been replaced with a phenoxy group.
According to Daniel Trachsel and colleagues in their book Phenethylamine: von der Struktur zur Funktion, phescaline is not known to have been synthesized, studied, or tested in humans. However, analogues of phescaline like benzscaline (BZ) and 3C-BZ are known to be potent serotonin 5-HT2A receptor agonists and/or psychedelics, and phescaline may be active as a psychedelic similarly. On the other hand, the longer-chain analogue phenescaline was found to have little activity in humans at tested doses.
Phescaline was first described in the literature by Trachsel and colleagues in Phenethylamine: von der Struktur zur Funktion in 2013.